Ameriprise Financial Inc. raised its holdings in shares of Mylan (NASDAQ:MYL) by 16.8% in the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 326,281 shares of the company’s stock after buying an additional 46,853 shares during the quarter. Ameriprise Financial Inc. owned about 0.06% of Mylan worth $10,228,000 as of its most recent SEC filing.

Several other hedge funds have also recently made changes to their positions in MYL. Pzena Investment Management LLC boosted its position in shares of Mylan by 84.1% during the 3rd quarter. Pzena Investment Management LLC now owns 22,721,384 shares of the company’s stock valued at $712,770,000 after acquiring an additional 10,381,697 shares during the last quarter. Vanguard Group Inc. boosted its position in shares of Mylan by 12.0% during the 2nd quarter. Vanguard Group Inc. now owns 32,880,790 shares of the company’s stock valued at $1,276,432,000 after acquiring an additional 3,531,974 shares during the last quarter. BlackRock Inc. boosted its position in shares of Mylan by 4.5% during the 2nd quarter. BlackRock Inc. now owns 40,574,158 shares of the company’s stock valued at $1,575,089,000 after acquiring an additional 1,751,515 shares during the last quarter. Schroder Investment Management Group boosted its position in shares of Mylan by 161,445.9% during the 2nd quarter. Schroder Investment Management Group now owns 1,731,772 shares of the company’s stock valued at $67,124,000 after acquiring an additional 1,730,700 shares during the last quarter. Finally, Teachers Advisors LLC boosted its position in shares of Mylan by 72.2% during the 2nd quarter. Teachers Advisors LLC now owns 3,346,814 shares of the company’s stock valued at $129,923,000 after acquiring an additional 1,403,273 shares during the last quarter. 74.90% of the stock is currently owned by hedge funds and other institutional investors.

Several research analysts have recently weighed in on the stock. BidaskClub raised shares of Mylan from a “buy” rating to a “strong-buy” rating in a research report on Tuesday. BMO Capital Markets reissued a “buy” rating and set a $45.00 price target on shares of Mylan in a research report on Friday, September 29th. ValuEngine raised shares of Mylan from a “hold” rating to a “buy” rating in a research report on Monday, October 2nd. Instinet reissued a “buy” rating and set a $37.00 price target on shares of Mylan in a research report on Thursday, October 5th. Finally, Cowen reissued a “market perform” rating and set a $36.00 price target (up previously from $30.00) on shares of Mylan in a research report on Thursday, October 5th. One research analyst has rated the stock with a sell rating, seven have given a hold rating, thirteen have issued a buy rating and one has given a strong buy rating to the stock. The stock has a consensus rating of “Buy” and an average price target of $42.41.

Mylan (NASDAQ:MYL) opened at $41.22 on Thursday. Mylan has a 1 year low of $29.39 and a 1 year high of $45.87. The company has a debt-to-equity ratio of 1.05, a current ratio of 1.46 and a quick ratio of 0.95. The company has a market cap of $22,120.00, a PE ratio of 8.87, a price-to-earnings-growth ratio of 2.28 and a beta of 1.38.

Mylan (NASDAQ:MYL) last posted its earnings results on Monday, November 6th. The company reported $1.10 EPS for the quarter, missing the Zacks’ consensus estimate of $1.20 by ($0.10). Mylan had a net margin of 7.28% and a return on equity of 20.63%. The company had revenue of $2.99 billion during the quarter, compared to analyst estimates of $3.09 billion. During the same period in the previous year, the company earned $1.38 EPS. The company’s quarterly revenue was down 2.3% compared to the same quarter last year. equities research analysts forecast that Mylan will post 4.56 EPS for the current fiscal year.

COPYRIGHT VIOLATION NOTICE: This report was originally reported by Watch List News and is owned by of Watch List News. If you are accessing this report on another publication, it was illegally copied and republished in violation of U.S. & international copyright law. The original version of this report can be read at https://www.watchlistnews.com/ameriprise-financial-inc-grows-stake-in-mylan-myl/1775515.html.

Mylan Profile

Mylan N.V. is a global pharmaceutical company. The Company develops, licenses, manufactures, markets and distributes generic and branded generic products for resale by others; specialty pharmaceuticals, and active pharmaceutical ingredients (APIs). It operates through two segments: Generics and Specialty.

Want to see what other hedge funds are holding MYL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Mylan (NASDAQ:MYL).

Institutional Ownership by Quarter for Mylan (NASDAQ:MYL)

Receive News & Ratings for Mylan Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mylan and related companies with MarketBeat.com's FREE daily email newsletter.